Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

被引：12
|
作者：
Ellis, Katrina L. [1 ,2 ]
Watts, Gerald F. [1 ,3 ]
机构：
[1] Univ Western Australia, Sch Med, 35 Stirling Highway, Crawley, WA 6009, Australia
[2] Univ Western Australia, Sch Biomed Sci, 35 Stirling Highway, Crawley, WA 6009, Australia
[3] Royal Perth Hosp, Dept Cardiol, Lipid Disorders Clin, GPO Box X2213, Perth, WA 6001, Australia
来源：
CARDIOLOGY CLINICS | 2018年 / 36卷 / 02期
关键词：
Lipoprotein(a); Atherosclerotic cardiovascular disease; Pharmacotherapy; Risk assessment; Models of care; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; DOUBLE-BLIND; TARGETING APOLIPOPROTEIN(A); VASCULAR RISK; CORONARY; APHERESIS; DYSLIPIDEMIA; OUTCOMES; THERAPY;
D O I：
10.1016/j.ccl.2017.12.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lipoprotein(a) is a low-density lipoprotein-like particle covalently bound to a glycoprotein called apolipoprotein(a) that is under potent genetic control. Plasma levels of lipoprotein(a) vary by up to 1000-fold among individuals, with 1 in 4 having levels that increase the risk of atherosclerotic cardiovascular disease. New evidence supports a causal role for lipoprotein(a) in atherosclerotic cardiovascular disease and aortic valve stenosis. Individuals with elevated lipoprotein(a) have a high life-time burden of atherosclerotic cardiovascular disease. This notion is important for coronary prevention. But is lipoprotein(a) ready for prime-time use in coronary prevention clinics?
引用
收藏
页码：287 / +
页数：13
相关论文
共 50 条
  • [31] Etomidate or Propofol for Deep Sedation Are These Agents Ready for Emergency Department Prime-Time Use?
    Tanabe, Paula
    Gilboy, Nicki
    [J]. ADVANCED EMERGENCY NURSING JOURNAL, 2007, 29 (02) : 87 - 97
  • [32] Are radiomics ready for clinical prime-time in PET/CT imaging?
    Cheze Le Rest, Catherine
    Hustinx, Roland
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (04): : 347 - 354
  • [33] Drug Eluting Stents in Primary PCI: Ready for Prime-Time?
    Majithia, Arjun
    Levy, Michael S.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (06) : 963 - 964
  • [34] Baroreflex stimulation for treating resistant hypertension: ready for the prime-time?
    Bolignano, Davide
    Coppolino, Giuseppe
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 (03) : 89 - 95
  • [35] Uric acid as a cardiorenal risk factor - ready for prime-time?
    Patel, K. H. K.
    Goldsmith, D. J. A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (07) : 796 - 801
  • [36] Right Ventricular Outflow Tract Pacing: Not Ready for Prime-Time
    S. Serge Barold
    Bengt Herweg
    [J]. Journal of Interventional Cardiac Electrophysiology, 2005, 13 : 39 - 46
  • [37] Therapeutic targeting of cell transition: ready for clinical prime-time?
    van der Vorst, Emiel P. C.
    Kovacic, Jason C.
    [J]. CARDIOVASCULAR RESEARCH, 2024, 120 (05) : e14 - e16
  • [38] Right ventricular outflow tract pacing: Not ready for prime-time
    Barold, SS
    Herweg, B
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2005, 13 (01) : 39 - 46
  • [39] PET/MR in neuro-oncology: is it ready for prime-time?
    Laudicella, Riccardo
    Iagaru, A.
    Minutoli, F.
    Gaeta, M.
    Baldari, S.
    Bisdas, S.
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2020, 8 (04) : 233 - 235
  • [40] PET/MR in neuro-oncology: is it ready for prime-time?
    Riccardo Laudicella
    A. Iagaru
    F. Minutoli
    M. Gaeta
    S. Baldari
    S. Bisdas
    [J]. Clinical and Translational Imaging, 2020, 8 : 233 - 235
12345